Title : Erlotinib as standard adjuvant therapy for resectable EGFR mutation-positive non-small cell lung cancer.

Pub. Date : 2019 Dec

PMID : 32038917






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Erlotinib as standard adjuvant therapy for resectable EGFR mutation-positive non-small cell lung cancer. erlotinib epidermal growth factor receptor Homo sapiens